<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39439102</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness-Valencia Region, Spain, 2010-2021.</ArticleTitle><Pagination><StartPage>e70017</StartPage><MedlinePgn>e70017</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70017</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.70017</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory viruses are known to represent a high burden in winter, yet the seasonality of many viruses remains poorly understood. Better knowledge of co-circulation and interaction between viruses is critical to prevention and management. We use &gt; 10-year active surveillance in the Valencia Region to assess seasonality and co-circulation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Over 2010-2021, samples from patients hospitalised for acute respiratory illness were analysed using multiplex real-time PCR to test for 9 viruses: influenza, respiratory syncytial virus (RSV), parainfluenza virus (PIV), rhino/enteroviruses (HRV/ENV), metapneumovirus (MPV), bocavirus, adenovirus, SARS-CoV-2 and non-SARS coronaviruses (HCoV). Winter seasonal patterns of incidence were examined. Instances of co-detection of multiple viruses in a sample were analysed and compared with expected values under a crude model of independent circulation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most viruses exhibited consistent patterns between years. Specifically, RSV and influenza seasons were clearly defined, peaking in December-February, as did HCoV and SARS-CoV-2. MPV, PIV and HRV/ENV showed less clear seasonality, with circulation outside the observed period. All viruses circulated in January, suggesting any pair had opportunity for co-infection. Multiple viruses were found in 4% of patients, with more common co-detection in children under 5 (9%) than older ages. Influenza co-detection was generally observed infrequently relative to expectation, while RSV co-detections were more common, particularly among young children.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identify characteristic patterns of viruses associated with acute respiratory hospitalisation during winter. Simultaneous circulation permits extensive co-detection of viruses, particularly in young children. However, virus combinations appear to differ in their rates of co-detection, meriting further study.</AbstractText><CopyrightInformation>© 2024 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shirreff</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4654-1254</Identifier><AffiliationInfo><Affiliation>Epidemiology and Modelling of Antibiotic Evasion (EMAE), Institut Pasteur, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anti-Infective Evasion and Pharmacoepidemiology Team, Université Paris-Saclay, UVSQ, Inserm, CESP, Montigny-Le-Bretonneux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaves</LastName><ForeName>Sandra S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>New Products &amp; Innovation, Sanofi Vaccines, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coudeville</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>New Products &amp; Innovation, Sanofi Vaccines, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengual-Chuliá</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7605-8175</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER-ESP, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mira-Iglesias</LastName><ForeName>Ainara</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6371-8229</Identifier><AffiliationInfo><Affiliation>CIBER-ESP, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puig-Barberà</LastName><ForeName>Joan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5783-0409</Identifier><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orrico-Sanchez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CIBER-ESP, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díez-Domingo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CIBER-ESP, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine Research Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Valencia Hospital Surveillance Network for the Study of Influenza and Other Respiratory Viruses (VAHNSI)</CollectiveName></Author><Author ValidYN="Y"><LastName>Opatowski</LastName><ForeName>Lulla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Epidemiology and Modelling of Antibiotic Evasion (EMAE), Institut Pasteur, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anti-Infective Evasion and Pharmacoepidemiology Team, Université Paris-Saclay, UVSQ, Inserm, CESP, Montigny-Le-Bretonneux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Labrador</LastName><ForeName>F Xavier</ForeName><Initials>FX</Initials><Identifier Source="ORCID">0000-0002-9403-8258</Identifier><AffiliationInfo><Affiliation>Virology Laboratory, Genomics and Health Area, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER-ESP, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Ecology, Medical School, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Inserm</Agency><Country /></Grant><Grant><GrantID>ANR-10-LABX-62-IBEID</GrantID><Agency>Agence Nationale de la Recherche</Agency><Country /></Grant><Grant><Agency>Sanofi</Agency><Country /></Grant><Grant><Agency>French National Institute for Health and Medical Research (Inserm)</Agency><Country /></Grant><Grant><Agency>Institut Pasteur</Agency><Country /></Grant><Grant><Agency>University of Versailles-Saint-Quentin-en-Yvelines/University of Paris-Saclay</Agency><Country /></Grant><Grant><Agency>CIBEResp Network of Excellence, Instituto de Salud Carlos III, Spain</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RSV respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">co‐detection</Keyword><Keyword MajorTopicYN="N">co‐infection</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">respiratory virus</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword><Keyword MajorTopicYN="N">seasonality</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>G.S. is funded by a Sanofi research grant through Institut Pasteur. S.S.C. and L.C. are employees of Sanofi and may hold shares in the company. J.D.D., A.M.I. and F.X.L.L. are employees at FISABIO foundation that have received funding from Sanofi and the Foundation for Influenza Epidemiology. A.M.I. has received fees for conferences/experts' meetings from Sanofi and for educational events from MSD. J.D.D. and his institution received grants from Sanofi and GSK related to RSV preventive strategies. J.D.D. acted as advisor for these immunisation strategies to Sanofi. L.O. received a research grant by Sanofi through Institut Pasteur. B.M.C. and J.P.B. declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39439102</ArticleId><ArticleId IdType="pmc">PMC11496384</ArticleId><ArticleId IdType="doi">10.1111/irv.70017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moriyama M., Hugentobler W. J., and Iwasaki A., “Seasonality of Respiratory Viral Infections,” Annual Review of Virology 7, no. 1 (2020): 83–101, 10.1146/annurev-virology-012420-022445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-012420-022445</ArticleId><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberle J. H., Aberle S. W., Redlberger‐Fritz M., Sandhofer M. J., and Popow‐Kraupp T., “Human Metapneumovirus Subgroup Changes and Seasonality During Epidemics,” The Pediatric Infectious Disease Journal 29, no. 11 (2010): 1016–1018, 10.1097/INF.0b013e3181e3331a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181e3331a</ArticleId><ArticleId IdType="pubmed">20489673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes M. T., Lee B. E., Kanji J. N., et al., “Seasonality of Respiratory Viruses at Northern Latitudes,” JAMA Network Open 4, no. 9 (2021): e2124650, 10.1001/jamanetworkopen.2021.24650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.24650</ArticleId><ArticleId IdType="pmc">PMC8446819</ArticleId><ArticleId IdType="pubmed">34529066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanobini P., Bonaccorsi G., Lorini C., et al., “Global Patterns of Seasonal Influenza Activity, Duration of Activity and Virus (Sub)type Circulation From 2010 to 2020,” Influenza and Other Respiratory Viruses 16, no. 4 (2022): 696–706, 10.1111/irv.12969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12969</ArticleId><ArticleId IdType="pmc">PMC9178051</ArticleId><ArticleId IdType="pubmed">35212157</ArticleId></ArticleIdList></Reference><Reference><Citation>Piret J. and Boivin G., “Viral Interference Between Respiratory Viruses,” Emerging Infectious Diseases 28, no. 2 (2022): 273–281, 10.3201/eid2802.211727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2802.211727</ArticleId><ArticleId IdType="pmc">PMC8798701</ArticleId><ArticleId IdType="pubmed">35075991</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Wang C., and Zhang Y., “Viral Coinfections,” Viruses 14, no. 12 (2022): 2645, 10.3390/v14122645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122645</ArticleId><ArticleId IdType="pmc">PMC9784482</ArticleId><ArticleId IdType="pubmed">36560647</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifonova I., Christova I., Madzharova I., et al., “Clinical Significance and Role of Coinfections With Respiratory Pathogens Among Individuals With Confirmed Severe Acute Respiratory Syndrome Coronavirus‐2 Infection,” Frontiers in Public Health 10 (2022): 959319, 10.3389/fpubh.2022.959319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.959319</ArticleId><ArticleId IdType="pmc">PMC9479447</ArticleId><ArticleId IdType="pubmed">36117597</ArticleId></ArticleIdList></Reference><Reference><Citation>Goka E., Vallely P., Mutton K., and Klapper P., “Influenza A Viruses Dual and Multiple Infections With Other Respiratory Viruses and Risk of Hospitalisation and Mortality,” Influenza and Other Respiratory Viruses 7, no. 6 (2013): 1079–1087, 10.1111/irv.12020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12020</ArticleId><ArticleId IdType="pmc">PMC4634299</ArticleId><ArticleId IdType="pubmed">23078095</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple M. G., Cowell A., Dove W., et al., “Dual Infection of Infants by Human Metapneumovirus and Human Respiratory Syncytial Virus Is Strongly Associated With Severe Bronchiolitis,” Journal of Infectious Diseases 191, no. 3 (2005): 382–386, 10.1086/426457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/426457</ArticleId><ArticleId IdType="pmc">PMC7109698</ArticleId><ArticleId IdType="pubmed">15633097</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapf A. J., Hardick J., McBryde B., et al., “Impact of Coinfection Status and Comorbidity on Disease Severity in Adult Emergency Department Patients With Influenza B,” Influenza and Other Respiratory Viruses 16, no. 2 (2022): 236–246, 10.1111/irv.12907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12907</ArticleId><ArticleId IdType="pmc">PMC8818819</ArticleId><ArticleId IdType="pubmed">34533270</ArticleId></ArticleIdList></Reference><Reference><Citation>Goka E. A., Vallely P. J., Mutton K. J., and Klapper P. E., “Single, Dual and Multiple Respiratory Virus Infections and Risk of Hospitalization and Mortality,” Epidemiology and Infection 143, no. 1 (2015): 37–47, 10.1017/S0950268814000302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268814000302</ArticleId><ArticleId IdType="pmc">PMC9206808</ArticleId><ArticleId IdType="pubmed">24568719</ArticleId></ArticleIdList></Reference><Reference><Citation>Petat H., Schuers M., Marguet C., et al., “Positive and Negative Viral Associations in Patients With Acute Respiratory Tract Infections in Primary Care: The ECOVIR Study,” Frontiers in Public Health 11 (2023): 1269805, 10.3389/fpubh.2023.1269805.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1269805</ArticleId><ArticleId IdType="pmc">PMC10706622</ArticleId><ArticleId IdType="pubmed">38074759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadha M., Prabhakaran A. O., Choudhary M. L., et al., “Multisite Surveillance for Influenza and Other Respiratory Viruses in India: 2016–2018,” PLOS Global Public Health 2, no. 11 (2022): e0001001, 10.1371/journal.pgph.0001001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0001001</ArticleId><ArticleId IdType="pmc">PMC10022084</ArticleId><ArticleId IdType="pubmed">36962617</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickbakhsh S., Mair C., Matthews L., et al., “Virus‐virus interactions impact the population dynamics of influenza and the common cold,” Proceedings of the National Academy of Sciences 116, no. 52 (2019): 27142–27150, 10.1073/pnas.1911083116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1911083116</ArticleId><ArticleId IdType="pmc">PMC6936719</ArticleId><ArticleId IdType="pubmed">31843887</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterlow N. R., Toizumi M., van Leeuwen E., et al., “Evidence for Influenza and RSV Interaction From 10 Years of Enhanced Surveillance in Nha Trang, Vietnam, a Modelling Study,” PLoS Computational Biology 18, no. 6 (2022): e1010234, 10.1371/journal.pcbi.1010234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1010234</ArticleId><ArticleId IdType="pmc">PMC9262224</ArticleId><ArticleId IdType="pubmed">35749561</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarin J. Z., Potter M., Thota J., et al., “Clinical Characteristics and Outcomes of Children With Single or Co‐Detected Rhinovirus‐Associated Acute Respiratory Infection in Middle Tennessee,” BMC Infectious Diseases 23, no. 1 (2023): 136, 10.1186/s12879-023-08084-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08084-4</ArticleId><ArticleId IdType="pmc">PMC9990557</ArticleId><ArticleId IdType="pubmed">36882755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanlapakorn N., Thongpan I., Sarawanangkoor N., et al., “Epidemiology and Clinical Characteristics of Severe Acute Respiratory Infections Among Hospitalized Children Under 5 Years of Age in a Tertiary Care Center in Bangkok, Thailand, 2019–2020,” Heliyon 9, no. 11 (2023): e22300, 10.1016/j.heliyon.2023.e22300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e22300</ArticleId><ArticleId IdType="pmc">PMC10692904</ArticleId><ArticleId IdType="pubmed">38045212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cason C., Zamagni G., Cozzi G., et al., “Spread of Respiratory Pathogens During the COVID‐19 Pandemic Among Children in the Northeast of Italy,” Frontiers in Microbiology 13 (2022): 804700, 10.3389/fmicb.2022.804700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.804700</ArticleId><ArticleId IdType="pmc">PMC8988150</ArticleId><ArticleId IdType="pubmed">35401434</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkoc G., Dogan C., Bayraktar S., Sahin K., and Elevli M., “Evaluation of Viral Respiratory Pathogens in Children Aged Under Five Hospitalized With Lower Respiratory Tract Infections,” Northern Clinics of Istanbul 9, no. 2 (2022): 162–172, 10.14744/nci.2021.69923.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/nci.2021.69923</ArticleId><ArticleId IdType="pmc">PMC9039642</ArticleId><ArticleId IdType="pubmed">35582505</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Chen S., Zhang X., Hong L., Zeng Y., and Wu B., “Detection and Clinical Characteristics Analysis of Respiratory Viruses in Hospitalized Children With Acute Respiratory Tract Infections by a GeXP‐Based Multiplex‐PCR Assay,” Journal of Clinical Laboratory Analysis 34, no. 4 (2019): e23127, 10.1002/jcla.23127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23127</ArticleId><ArticleId IdType="pmc">PMC7147121</ArticleId><ArticleId IdType="pubmed">31774213</ArticleId></ArticleIdList></Reference><Reference><Citation>El Kholy A. A., Mostafa N. A., Ali A. A., et al., “The Use of Multiplex PCR for the Diagnosis of Viral Severe Acute Respiratory Infection in Children: A High Rate of co‐Detection During the Winter Season,” European Journal of Clinical Microbiology &amp; Infectious Diseases 35, no. 10 (2016): 1607–1613, 10.1007/s10096-016-2698-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-016-2698-5</ArticleId><ArticleId IdType="pmc">PMC7088036</ArticleId><ArticleId IdType="pubmed">27287764</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig‐Barberà J., Tormos A., Trushakova S., et al., “The Global Influenza Hospital Surveillance Network (GIHSN): A New Platform to Describe the Epidemiology of Severe Influenza,” Influenza and Other Respiratory Viruses 9, no. 6 (2015): 277–286, 10.1111/irv.12335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12335</ArticleId><ArticleId IdType="pmc">PMC4605407</ArticleId><ArticleId IdType="pubmed">26198771</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Bose M. E., Beck E. T., et al., “Rapid Multiplex Reverse Transcription‐PCR Typing of Influenza A and B Virus, and Subtyping of Influenza A Virus Into H1, 2, 3, 5, 7, 9, N1 (Human), N1 (Animal), N2, and N7, Including Typing of Novel Swine Origin Influenza A (H1N1) Virus, During the 2009 Outbreak in Milwaukee, Wisconsin,” Journal of Clinical Microbiology 47, no. 9 (2009): 2772–2778, 10.1128/JCM.00998-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00998-09</ArticleId><ArticleId IdType="pmc">PMC2738083</ArticleId><ArticleId IdType="pubmed">19641063</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwannakarn K., Payungporn S., Chieochansin T., et al., “Typing (A/B) and Subtyping (H1/H3/H5) of Influenza A Viruses by Multiplex Real‐Time RT‐PCR Assays,” Journal of Virological Methods 152, no. 1–2 (2008): 25–31, 10.1016/j.jviromet.2008.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2008.06.002</ArticleId><ArticleId IdType="pubmed">18598722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuypers J., Martin E. T., Heugel J., Wright N., Morrow R., and Englund J. A., “Clinical Disease in Children Associated With Newly Described Coronavirus Subtypes,” Pediatrics 119, no. 1 (2007): e70–e76, 10.1542/peds.2006-1406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-1406</ArticleId><ArticleId IdType="pubmed">17130280</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki Y., Takashita E., Okamoto M., et al., “Evaluation of a New Rapid Antigen Test Using Immunochromatography for Detection of Human Metapneumovirus in Comparison With Real‐Time PCR Assay,” Journal of Clinical Microbiology 47, no. 9 (2009): 2981–2984, 10.1128/JCM.00321-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00321-09</ArticleId><ArticleId IdType="pmc">PMC2738101</ArticleId><ArticleId IdType="pubmed">19571031</ArticleId></ArticleIdList></Reference><Reference><Citation>Neske F., Blessing K., Tollmann F., et al., “Real‐Time PCR for Diagnosis of Human Bocavirus Infections and Phylogenetic Analysis,” Journal of Clinical Microbiology 45, no. 7 (2007): 2116–2122, 10.1128/jcm.00027-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00027-07</ArticleId><ArticleId IdType="pmc">PMC1932993</ArticleId><ArticleId IdType="pubmed">17475762</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Pol A. C., van Loon A. M., Wolfs T. F. W., et al., “Increased Detection of Respiratory Syncytial Virus, Influenza Viruses, Parainfluenza Viruses, and Adenoviruses With Real‐Time PCR in Samples From Patients With Respiratory Symptoms,” Journal of Clinical Microbiology 45, no. 7 (2007): 2260–2262, 10.1128/JCM.00848-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00848-07</ArticleId><ArticleId IdType="pmc">PMC1932984</ArticleId><ArticleId IdType="pubmed">17507513</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Cordey S., Van Belle S., et al., “New Molecular Detection Tools Adapted to Emerging Rhinoviruses and Enteroviruses,” Journal of Clinical Microbiology 47, no. 6 (2009): 1742–1749, 10.1128/JCM.02339-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02339-08</ArticleId><ArticleId IdType="pmc">PMC2691104</ArticleId><ArticleId IdType="pubmed">19339471</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO
. WHO Molecular Diagnosis of Influenza Virus in Humans. Published online August 2011. Accessed September 8, 2020, http://www.who.int/influenza/resources/documents/molecular_diagnosis_influenza_virus_humans_update_201108.pdf.</Citation></Reference><Reference><Citation>Kamau E., Agoti C. N., Lewa C. S., et al., “Recent Sequence Variation in Probe Binding Site Affected Detection of Respiratory Syncytial Virus Group B by Real‐Time RT‐PCR,” Journal of Clinical Virology 88 (2017): 21–25, 10.1016/j.jcv.2016.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.12.011</ArticleId><ArticleId IdType="pmc">PMC5331890</ArticleId><ArticleId IdType="pubmed">28107671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mira‐Iglesias A., Mengual‐Chuliá B., Cano L., et al., “Retrospective Screening for SARS‐CoV‐2 Among Influenza‐Like Illness Hospitalizations: 2018–2019 and 2019–2020 Seasons, Valencia Region, Spain,” Influenza and Other Respiratory Viruses 16, no. 1 (2022): 166–171, 10.1111/irv.12899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12899</ArticleId><ArticleId IdType="pmc">PMC8652788</ArticleId><ArticleId IdType="pubmed">34528756</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech de Cellès M., Arduin H., Varon E., et al., “Characterizing and Comparing the Seasonality of Influenza‐Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms,” American Journal of Epidemiology 187, no. 5 (2018): 1029–1039, 10.1093/aje/kwx336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx336</ArticleId><ArticleId IdType="pubmed">29053767</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team
, R: A Language and Environment for Statistical Computing (Vienna, Austria: R Foundation for Statistical Computing, 2022), https://www.R‐project.org/.</Citation></Reference><Reference><Citation>
CoVariants
. Accessed July 22, 2024, https://covariants.org/per‐variant?country=Spain.</Citation></Reference><Reference><Citation>García‐Arroyo L., Prim N., Del Cuerpo M., et al., “Prevalence and Seasonality of Viral Respiratory Infections in a Temperate Climate Region: A 24‐Year Study (1997–2020),” Influenza and Other Respiratory Viruses 16, no. 4 (2022): 756–766, 10.1111/irv.12972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12972</ArticleId><ArticleId IdType="pmc">PMC9178050</ArticleId><ArticleId IdType="pubmed">35170253</ArticleId></ArticleIdList></Reference><Reference><Citation>Opatowski L., Baguelin M., and Eggo R. M., “Influenza Interaction With Cocirculating Pathogens and Its Impact on Surveillance, Pathogenesis, and Epidemic Profile: A Key Role for Mathematical Modelling,” PLoS Pathogens 14, no. 2 (2018): e1006770, 10.1371/journal.ppat.1006770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006770</ArticleId><ArticleId IdType="pmc">PMC5814058</ArticleId><ArticleId IdType="pubmed">29447284</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organisation
. Flunet. Accessed July 22, 2024, https://www.who.int/tools/flunet.</Citation></Reference><Reference><Citation>Lee Y. J., Lee J. Y., Jang Y. H., Seo S. U., Chang J., and Seong B. L., “Non‐Specific Effect of Vaccines: Immediate Protection Against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine,” Frontiers in Microbiology 9 (2018): 9, 10.3389/fmicb.2018.00083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00083</ArticleId><ArticleId IdType="pmc">PMC5797773</ArticleId><ArticleId IdType="pubmed">29445364</ArticleId></ArticleIdList></Reference><Reference><Citation>Walzl G., Tafuro S., Moss P., Openshaw P. J. M., and Hussell T., “Influenza Virus Lung Infection Protects From Respiratory Syncytial Virus–Induced Immunopathology,” Journal of Experimental Medicine 192, no. 9 (2000): 1317–1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193356</ArticleId><ArticleId IdType="pubmed">11067880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin G. L., Drysdale S. B., Snape M. D., et al., “Association Between Disease Severity and Co‐Detection of Respiratory Pathogens in Infants With RSV Infection,” Published online February 15, (2023): 23285726, 10.1101/2023.02.12.23285726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.12.23285726</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto A. S., DeJonge P. M., Callear A. P., et al., “Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan,” Journal of Infectious Diseases 222, no. 1 (2020): 9–16, 10.1093/infdis/jiaa161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa161</ArticleId><ArticleId IdType="pmc">PMC7184402</ArticleId><ArticleId IdType="pubmed">32246136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maykowski P., Smithgall M., Zachariah P., et al., “Seasonality and Clinical Impact of Human Parainfluenza Viruses,” Influenza and Other Respiratory Viruses 12, no. 6 (2018): 706–716, 10.1111/irv.12597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12597</ArticleId><ArticleId IdType="pmc">PMC6185891</ArticleId><ArticleId IdType="pubmed">30051619</ArticleId></ArticleIdList></Reference><Reference><Citation>Franczuk P., Tkaczyszyn M., Kulak M., Domenico E., Ponikowski P., and Jankowska E. A., “Cardiovascular Complications of Viral Respiratory Infections and COVID‐19,” Biomedicine 11, no. 1 (2022): 71, 10.3390/biomedicines11010071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11010071</ArticleId><ArticleId IdType="pmc">PMC9856218</ArticleId><ArticleId IdType="pubmed">36672579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin T., Foxman E. F., Watkins T. A., and Lipsitch M., “Considerations for Viral Co‐Infection Studies in Human Populations,” MBio 15 (2024): e0065824, 10.1128/mbio.00658-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00658-24</ArticleId><ArticleId IdType="pmc">PMC11253623</ArticleId><ArticleId IdType="pubmed">38847531</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech de Cellès M., Goult E., Casalegno J. S., and Kramer S. C., “The Pitfalls of Inferring Virus‐Virus Interactions From Co‐Detection Prevalence Data: Application to Influenza and SARS‐CoV‐2,” Proceedings of the Biological Sciences 2022, no. 289 (1966): 20212358, 10.1098/rspb.2021.2358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2021.2358</ArticleId><ArticleId IdType="pmc">PMC8753173</ArticleId><ArticleId IdType="pubmed">35016540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacevic A., Eggo R. M., Baguelin M., Domenech de Cellès M., and Opatowski L., “The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS‐CoV‐2 Percentage Positivity,” Journal of Infectious Diseases 225, no. 2 (2022): 199–207, 10.1093/infdis/jiab459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab459</ArticleId><ArticleId IdType="pmc">PMC8763960</ArticleId><ArticleId IdType="pubmed">34514500</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao A. T., Tong Y. X., Gao C., Zhu L., Zhang Y. J., and Zhang S., “Dynamic Profile of RT‐PCR Findings From 301 COVID‐19 Patients in Wuhan, China: A Descriptive Study,” Journal of Clinical Virology 127 (2020): 104346, 10.1016/j.jcv.2020.104346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104346</ArticleId><ArticleId IdType="pmc">PMC7151472</ArticleId><ArticleId IdType="pubmed">32361324</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H. C., Papanikolopoulou A., Vassiliu S., Theodoridou K., Nikolopoulou G., and Sipsas N. V., “COVID‐19 and Respiratory Virus Co‐Infections: A Systematic Review of the Literature,” Viruses 15, no. 4 (2023): 865, 10.3390/v15040865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040865</ArticleId><ArticleId IdType="pmc">PMC10142898</ArticleId><ArticleId IdType="pubmed">37112844</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J., “Will Viral Interference Hold off the Tripledemic?,” Science 378, no. 6622 (2022): 814–815, 10.1126/science.adf8989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adf8989</ArticleId><ArticleId IdType="pubmed">36423297</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega‐Alonso T., Lozano‐Alonso J. E., and Ordax‐Díez A., “Comprehensive Surveillance of Acute Respiratory Infections During the COVID‐19 Pandemic: A Methodological Approach Using Sentinel Networks, Castilla y León, Spain, January 2020 to May 2022,” Euro Surveillance 28, no. 21 (2023): 2200638, 10.2807/1560-7917.ES.2023.28.21.2200638.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.21.2200638</ArticleId><ArticleId IdType="pmc">PMC10283458</ArticleId><ArticleId IdType="pubmed">37227298</ArticleId></ArticleIdList></Reference><Reference><Citation>
ECDC
. Seasonal influenza 2021–2022—Annual Epidemiological Report. Published online 2021, https://www.ecdc.europa.eu/en/publications‐data/seasonal‐influenza‐annual‐epidemiological‐report‐2021‐2022.</Citation></Reference><Reference><Citation>
WHO Coronavirus Disease (COVID‐19) Dashboard. Accessed October 14, 2020, https://covid19.who.int.</Citation></Reference><Reference><Citation>
ECDC
. Seasonal Influenza 2022–2023 Annual Epidemiological Report for 2023; 2023. Accessed July 21, 2023, https://www.ecdc.europa.eu/sites/default/files/documents/seasonal‐influenza‐annual‐epidemiological‐report‐2022‐2023.pdf.</Citation></Reference><Reference><Citation>
ECDC
. Intensified Circulation of Respiratory Syncytial Virus (RSV) and Associated Hospital Burden in the EU/EEA. Published December 12, 2022. Accessed August 11, 2023, https://www.ecdc.europa.eu/en/publications‐data/intensified‐circulation‐respiratory‐syncytial‐virus‐rsv‐and‐associated‐hospital.</Citation></Reference><Reference><Citation>De Luca D., Sanchez‐Luna M., Schettler K., Bont L., and Baraldi E., “Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt,” Lancet Regional Health Europe 34 (2023): 100753, 10.1016/j.lanepe.2023.100753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100753</ArticleId><ArticleId IdType="pmc">PMC10624979</ArticleId><ArticleId IdType="pubmed">37927432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>